Home PageNews PagePear Therapeutics Pear Therapeutics to Be Added to Russell US Index Series Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription…Arboretum_JDAugust 3, 2022
Home PageNews PagePear Therapeutics Pear Therapeutics and Thimble Point Announce Closing of Business Combination to Create Publicly Traded Company Pear Therapeutics, Inc. (“Pear Therapeutics”), the leader in developing and commercializing software-based medicines, called prescription…Arboretum_JDDecember 6, 2021
News PagePear Therapeutics Pear Therapeutics Receives FDA Breakthrough Device Designation for Prescription Digital Therapeutic Candidate to Treat Alcohol Use Disorder Pear Therapeutics, Inc., the leader in developing and commercializing software-based medicines called prescription digital therapeutics…Arboretum_JDNovember 23, 2021
News PagePear Therapeutics Pear Therapeutics Announces Formulary Availability for its Three FDA Authorized Prescription Digital Therapeutics at OptumRX Pear Therapeutics, Inc. today announced formulary availability of its commercial products at OptumRx, Inc., the…Arboretum_JDAugust 10, 2021
News PagePear Therapeutics Pear Therapeutics Announces Publication of Data Analysis Showing Real-World Cost Impact of ReSET-O® Pear Therapeutics, Inc., today announced publication of a new analysis demonstrating the real-world cost impact…Arboretum_JDJuly 28, 2021
Home PageNews PagePear Therapeutics Pear Therapeutics to Become a Public Company Pear Therapeutics, Inc. (“Pear”), the leader in developing and commercializing prescription digital therapeutics (PDTs) to…Arboretum_JDJune 22, 2021
Pear Therapeutics Pear Therapeutics Announces Second Closing of Series D Financing Pear Therapeutics, Inc., recently announced the second closing of its Series D financing. The second…Arboretum_JDMarch 3, 2021
Home PageNews PagePear Therapeutics Pear Therapeutics Completes $80M Series D Financing Led by Softbank Vision Fund 2 Pear Therapeutics, Inc., (“Pear” or the “Company”) today announced that it has successfully closed an…Arboretum_JDDecember 8, 2020
Pear Therapeutics Pear Therapeutics Launches Somryst for the Treatment of Chronic Insomnia Pear Therapeutics, Inc., recently announced the availability of Somryst™, the first prescription digital therapeutic (PDT)…Arboretum_JDNovember 17, 2020
Pear Therapeutics Pear Therapeutics Wins Prix Galien USA Award for Somryst™ as Best Digital Health Product Pear Therapeutics, Inc. recently announced that the Galien Foundation has awarded the 2020 Prix Galien…Arboretum_JDNovember 2, 2020